GL1X · GenesisL1 explorer

Research workbench

6XOQ: DCN1 covalently bound to inhibitor 4

Analyse 6XOQ: DCN1 covalently bound to inhibitor 4 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6XOQ
Type
protein
Length
357 residues
Chains
1
Method
x-ray diffraction
Authors
Stuckey, J.A.
Deposited
07/07/20
Collection
MolNFT v2 / PDB Bank
Contract
0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
Owner
0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8
Resolution
2.07
Source
Enterobacteria phage T4; Homo sapiens
Molecule
Lysozyme, DCN1-like protein 1 chimera
EC
3.2.1.17
UniProt
D9IEF7, Q96GG9
Ligands
H9S
Pockets
5 · best druggability 0.70

Structure

x-ray diffraction · resolution 2.07 · 1 distinct chain · 63% helix, 7% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ALysozyme, DCN1-like protein 1 chimera (EC 3.2.1.17)protein35763% helix, 7% strandD9IEF7, Q96GG9

Ligands and binding sites

  • H9S · (2E)-N-[(2S)-2-cyclohexyl-2-({N-propanoyl-3-[6-(propan-2-yl)-1,3-benzothiazol-2-yl]-L-alanyl}amino)ethyl]-4-(morpholin-4-yl)but-2-enamide · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11640.700.8824H9S
23350.580.7639empty
3850.350.7517empty
4590.290.7515empty
5670.280.7319empty

Compared structures

  • 6XOQ · DCN1 covalently bound to inhibitor 4 · the same entry in another collection · chain A against A, TM-score 1.00
  • Q96GG9 · AlphaFold monomer V2.0 prediction for DCN1-like protein 1 (Q96GG9) · a predicted model of the same protein · chain A against A, TM-score 0.59

Analyse

Other records of 6XOQ

  • 6XOQ-2 · MolNFT v1 / PDB · DCN1 covalently bound to inhibitor 4

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.